Avesta Pharma Private Limited, a active private limited company, was established on 25 May 2009 in Mumbai, Maharashtra, India. Engaging in plastic & resins within the manufacturing sector, it holds CIN: U24239MH2009PTC192677. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a compliant status. Employing 124 professional, Its leadership includes Eric Kersi Tangri (Director), Zubin Keki Gandhi (Director), Amol Ashok Walke (Director). Past directors included Eric Kersi Tangri, Sonal Kersi Tangri, Amol Ashok Walke. It holds ₹55.90 Cr open charges and ₹25.91 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 106 / 108 , Shivam Chambers, 1St Floor S.V.Road, Goregaon West, Mumbai, Maharashtra, 400062.
U24239MH2009PTC192677
192677
25 May 2009
₹2.00 Cr
₹2.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Avesta Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Eric Kersi Tangri | Director | 01 Mar 2024 | Current |
| Zubin Keki Gandhi | Director | 30 Nov 2009 | Current |
| Amol Ashok Walke | Director | 01 Apr 2015 | Current |
| Mahesh Hakmichand Doshi | Director | 01 Apr 2015 | Current |
| Kersi Homi Tangri | Director | 25 May 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 03 Feb 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avesta Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.19% increase. The company also saw a substantial improvement in profitability, with a 139.25% increase in profit. The company's net worth Soared by an impressive increase of 224.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Avesta Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹558,950,000.00
₹259,075,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Aug 2021 | Others | ₹55.90 Cr | Open |
| 18 Aug 2011 | Bank Of India | ₹18.00 Cr | Satisfied |
| 18 Aug 2011 | Bank Of India | ₹7.91 Cr | Satisfied |
Explore comprehensive loan charge details -
Avesta Pharma has a workforce of 124 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Avesta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avesta Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Avesta Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Avesta Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Eric Kersi Tangri was appointed as a Director was appointed as a Director on 01 Mar 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
The activity A charge with Others of Rs. 55.90 Cr registered on 03 Aug 2021 with Charge ID 100480251 was modified on 15 Mar 2023. was completed.
The activity A charge with Others amounted to Rs. 55.90 Cr with Charge ID 100480251 was registered on 03 Aug 2021. was completed.
A charge registered on 18 Aug 2011 via Charge ID 10310347 with Bank Of India was fully satisfied on 12 Jul 2021. was recorded as a recent event.
The CIN of Avesta Pharma Private Limited is U24239MH2009PTC192677.
Avesta Pharma Private Limited is headquartered at 106 / 108 , Shivam Chambers, 1St Floor S.V.Road, Goregaon West, Mumbai, Maharashtra, 400062.
Avesta Pharma Private Limited was incorporated on 25 May 2009.
The current directors of Avesta Pharma Private Limited are
The primary industry of Avesta Pharma Private Limited is Manufacturing.
Avesta Pharma Private Limited is unlisted.
The authorized capital of Avesta Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Avesta Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX